Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma.

Yan, Xin; Zhang, Xiao; Wu, Hua-Hui; Wu, Shao-Jie; Tang, Xiao-Yu; Liu, Tong-Zu; Li, Sheng

Yan, Xin; Zhang, Xiao; Wu, Hua-Hui; Wu, Shao-Jie; Tang, Xiao-Yu; Liu, Tong-Zu; Li, Sheng.

Afiliación

Yan X; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhang X; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wu HH; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wu SJ; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Tang XY; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liu TZ; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Li S; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Front Immunol ; 13: 994594, 2022.

Article en En | MEDLINE | ID: mdl-36466869

Asunto(s)

Carcinoma de Células Transicionales; Neoplasias de la Vejiga Urinaria; Humanos; Algoritmos; Carcinoma de Células Transicionales/terapia; Factores Inmunológicos; Inmunoterapia; Linfocitos T; Vejiga Urinaria; Neoplasias de la Vejiga Urinaria/terapia

Palabras clave

T cell; bladder urothelial carcinoma; drugs; immunotherapy; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google